SCHEMBL6520356

SCHEMBL6520356

C=C(c1ccc(Cl)cc1)c1ccccc1C=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR4A1 P22736 1/20 0.42
MAPT P10636 3/20 0.41
MAPK1 P28482 1/20 0.41
LMNA P02545 2/20 0.40
CES2 O00748 2/20 0.40
CES1 P23141 2/20 0.40
TDP1 Q9NUW8 2/20 0.40
MEN1 O00255 1/20 0.40
THRB P10828 1/20 0.40
BLM P54132 1/20 0.40
KMT2A Q03164 1/20 0.40
TRIM24 O15164 1/20 0.38
TRIM33 Q9UPN9 1/20 0.38
NPC1 O15118 3/20 0.38
CYP2D6 P10635 2/20 0.38
CYP2C9 P11712 2/20 0.38
KDM4E B2RXH2 2/20 0.38
RAB9A P51151 2/20 0.38
ALDH1A1 P00352 1/20 0.38
HTT P42858 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10978285 0.85 KMT2A (0.46) MAPK1LMNACES2CES1TDP1
SCHEMBL6525700 0.82 PARP1 (0.42) MAPTLMNATDP1MEN1THRB
SCHEMBL4557072 0.81 TDP1 (0.39) LMNATDP1MEN1THRBBLM
SCHEMBL11608426 0.81 NR4A1 (0.61) NR4A1MAPTMAPK1CES2CES1
SCHEMBL1663839 0.79 CES2 (0.45) LMNACES2CES1TDP1MEN1
SCHEMBL2933370 0.76 RAB9A (0.46) NR4A1CES2CES1KMT2ANPC1
SCHEMBL28603923 0.75 NR4A1 (0.68) NR4A1MAPTLMNACES2CES1
Hydrochloric Acid SCHEMBL27669623 0.74 RAB9A (0.45) NR4A1LMNACES2CES1KMT2A
SCHEMBL18892397 0.74 NR4A1 (0.43) NR4A1MAPTLMNACES2CES1
SCHEMBL25567804 0.73 NR4A1 (0.41) NR4A1MAPTMAPK1LMNACES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8680150-B2 Small molecule hematopoietic growth factor mimetic compounds that activate hematopoietic growth factor receptors LIGAND PHARMACEUTICALS, INC. (US) 2014-03-25 US disclosed
US-20110003851-A1 SMALL MOLECULE HEMATOPOIETIC GROWTH FACTOR MIMETIC COMPOUNDS THAT ACTIVATE HEMATOPOIETIC GROWTH FACTOR RECEPTORS LIGAND PHARMACEUTICALS, INC. (US) 2011-01-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110003851-A1 SMALL MOLECULE HEMATOPOIETIC GROWTH FACTOR MIMETIC COMPOUNDS THAT ACTIVATE HEMATOPOIETIC GROWTH FACTOR RECEPTORS MPL, CSF3R, CSF1R NR4A1 1116/4885MAPT 4690/4885MAPK1 1715/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.